ghk-cu 5-alpha reductase inhibition Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application Copper Peptides vs. Dutasteride for

Oral GHK-Cu is more convenient but faces significant absorption challenges due to enzymatic degradation in the digestive tract

Pulmonary Conditions GHK-Cu has shown promising results in the treatment of bleomycin-induced pulmonary fibrosis, a model for idiopathic pulmonary fibrosis (IPF)

GHK-Cu has also been studied in models of acute lung injury (ALI), where it demonstrates protective effects by reducing reactive oxygen species (ROS) production and increasing antioxidant enzyme activity

There are many ways to reduce toxin load

As humans age, their natural levels of GHK decline, going from around 200ng/mL in the plasma of a 20-year-old to 80ng/mL in a 60-year-old